Yao Wenqing Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 months, 2 weeks ago
Yao Wenqing has an estimated net worth of at least $10.4 million*, as of Nov. 13, 2024. They own 98,575 shares of INCY stock. They have sold 27,194 shares of INCY stock since 2021, for an estimated $2.3 million.
Yao Wenqing $INCY SEC Form 4 Insider Trading
Yao Wenqing has filed a total of 1 insider trades in $INCY since 2021. Their most recent trade was a sale of 27,194 shares, made on Jun 29, 2021. Their largest trade was a sale of 27,194 shares, made on Jun 29, 2021. We estimate that they now own 98,575 shares of $INCY, worth an estimated $8.0 million.
Insider Trading at $INCY
There have been a total of 96 insider trades reported at $INCY since 2021, with 4.1 million shares purchased and 408,301 shares sold. The most active insider traders in $INCY stock have been Barry P Flannelly, Vijay K Iyengar, and Thomas Tray. The most recent trade was a sale of 599 shares reported by Sheila A. Denton (EVP & General Counsel), made on Mar 04, 2025.
History of Insider Stock Trades by Yao Wenqing
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 27,194 | Jun 29, 2021 | June 29, 2021, 8 p.m. |
$INCY Executives and Stock Owners with Insider Trades
-
Barry P Flannelly, EVP & General Manager US
-
Vijay K Iyengar, EVP, GMAPPS
-
Thomas Tray, Principal Accounting Officer
-
Maria E Pasquale, EVP & General Counsel
-
Dashyant Dhanak, EVP & Chief Scientific Officer
-
Steven H Stein, EVP & Chief Medical Officer
-
Jonathan Elliott Dickinson, EVP, General Manager, Europe
-
Paula J Swain, EVP, Human Resources
-
Sheila A. Denton, EVP & General Counsel
-
Paul Trower, Principal Accounting Officer
-
Vijay K Iyengar, EVP GPS, BD, & Licensing
-
Yao Wenqing, EVP, Head of Discovery Chem
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.